Smoking Treatment of Prisoners

NCT00110630 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

NIH

Sponsor class

Conditions

Tobacco Use Cessation
Tobacco Use Disorder

Interventions

BEHAVIORAL: 10-week smoking cessation group therapy combined with NicoDerm CQ

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]